We are live on ! Find out more
INVA icon

Innoviva

193 hedge funds and large institutions have $1.06B invested in Innoviva in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 74 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

318% more call options, than puts

Call options by funds: $25.5M | Put options by funds: $6.1M

36% more capital invested

Capital invested by funds: $778M → $1.06B (+$282M)

1.05% more ownership

Funds ownership: 72.89%73.94% (+1%)

8% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 25

4% less funds holding

Funds holding: 201193 (-8)

19% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 74

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
193
Holders Change
-8
Holders Change %
-3.98%
% of All Funds
3.8%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
23
Increased
60
Reduced
74
Closed
25
Calls
$25.5M
Puts
$6.1M
Net Calls
+$19.4M
Net Calls Change
+$11.2M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$163M +$3.29M +268,027 +2%
Renaissance Technologies
2
Renaissance Technologies
New York
$112M +$3.83M +312,010 +4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$96.4M +$975K +79,484 +1%
SCM
4
Sarissa Capital Management
Connecticut
$88.4M
LSV Asset Management
5
LSV Asset Management
Illinois
$46.8M -$968K -78,900 -2%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$34.1M -$2.81M -229,258 -9%
Invesco
7
Invesco
Georgia
$30.2M +$4.89M +398,254 +23%
State Street
8
State Street
Massachusetts
$29.2M -$375K -30,551 -1%
Bank of America
9
Bank of America
North Carolina
$26.4M +$5.07M +413,490 +28%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$23.9M +$1.85M +150,974 +10%
First Eagle Investment Management
11
First Eagle Investment Management
New York
$23.6M +$5.12M +417,600 +33%
Arrowstreet Capital
12
Arrowstreet Capital
Massachusetts
$21M +$13.5M +1,098,054 +285%
Man Group
13
Man Group
United Kingdom
$18.8M -$2.27M -185,238 -12%
Norges Bank
14
Norges Bank
Norway
$17.3M
Nomura Holdings
15
Nomura Holdings
Japan
$16.9M +$1.75M +142,509 +14%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$14.6M +$618K +50,350 +5%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$13.4M +$350K +28,488 +3%
Northern Trust
18
Northern Trust
Illinois
$12.6M -$298K -24,308 -3%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$11.6M +$276K +22,475 +3%
WG
20
Winton Group
United Kingdom
$10.9M +$7.38M +601,415 +363%
AI
21
Atom Investors
Texas
$10.7M -$1.25M -101,621 -12%
Connor, Clark & Lunn Investment Management (CC&L)
22
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$8.45M -$1.61M -131,000 -18%
Schroder Investment Management Group
23
Schroder Investment Management Group
United Kingdom
$8.43M +$334K +27,212 +5%
N
24
Nuveen
North Carolina
$8.43M +$248K +20,178 +4%
MCM
25
Matarin Capital Management
New York
$8.43M -$3.3M -269,201 -31%

INVA Hedge Fund Activity: Q4 2019 in Review

193 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2019, worth a combined $1.06B — up 36% from $778M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of INVA and 23 opened new positions — a net loss of 2 holders — while 74 trimmed existing stakes and 60 added.

The largest buyer was Arrowstreet Capital, adding an estimated $13.5M. The largest seller was Marshall Wace, cutting an estimated $5.68M.

  • 193 institutional investors held Innoviva (INVA) as of Q4 2019, down from 201 in Q3 2019.
  • Funds reported $1.06B of Innoviva stock for Q4 2019, up 36% quarter-over-quarter.
  • 23 funds opened new Innoviva positions in Q4 2019 and 25 closed out, a net change of -2 holders.
  • The largest Innoviva buyer in Q4 2019 was Arrowstreet Capital, an estimated $13.5M added.
  • The largest Innoviva seller in Q4 2019 was Marshall Wace, an estimated $5.68M sold.

Based on aggregated 13F filings for Q4 2019.